Cogent Biosciences
Latest round
- Series B
Last raised
- Jun 2015
Total raised
- $71M
Investors
- 12
About Cogent Biosciences
operates as a biopharmaceutical company that develops cellular immunotherapies for the treatment of cancer. As of 2024, the company is traded at Nasdaq exchange with ticker symbol COGT. In February 2024, Cogent Biosciences, Inc. Cogent Biosciences, Inc. developed a product known as bezuclastinib, which is a selective inhibitor targeting exon 17 mutations within the KIT receptor tyrosine kinase, including the KIT D816V mutation. It supports mutation in Systemic Mastocytosis, a rare disease characterized by the accumulation of mast cells in various organs. The company’s product also developed for advanced gastrointestinal stromal tumors (GIST), which are for oncogenic KIT signaling. In addition, the firm’s drug is in early clinical results in Phase 1/2 trials, for treating cancer.
Who invested in Cogent Biosciences
12 investors across 2 rounds
See all investors in Cogent Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cogent Biosciences
Who invested in Cogent Biosciences?
Cogent Biosciences has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cogent Biosciences raised?
Cogent Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cogent Biosciences last raise money?
Cogent Biosciences's most recent round on record is a Series B, in Jun 2015.
What does Cogent Biosciences do?
operates as a biopharmaceutical company that develops cellular immunotherapies for the treatment of cancer.
Where is Cogent Biosciences headquartered?
Cogent Biosciences is headquartered in Waltham, US.
Which VCs invest in companies like Cogent Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cogent Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cogent Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.